Statistics for The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance
Total visits
views | |
---|---|
The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance | 258 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
File Visits
views | |
---|---|
oncotarget-08-108534.pdf | 192 |
java.util.UUID:fc358255-f7eb-4350-952b-c70556d3ed9f | 62 |
java.util.UUID:1b805807-8714-4043-b72e-4cf176b73eb0 | 13 |
java.util.UUID:201c6ebd-d62c-498f-a1da-fae72b4ab8ac | 9 |
Top country views
views | |
---|---|
United States | 189 |
Germany | 10 |
Russia | 7 |
Ukraine | 6 |
United Kingdom | 4 |
Sweden | 4 |
Canada | 2 |
China | 2 |
Vietnam | 2 |
Austria | 1 |
France | 1 |
Greece | 1 |
Iran | 1 |
Malaysia | 1 |
Pakistan | 1 |
Poland | 1 |
Top city views
views | |
---|---|
Wilmington | 49 |
Fairfield | 31 |
Ann Arbor | 18 |
Cambridge | 9 |
Houston | 9 |
Jacksonville | 7 |
Kiev | 6 |
Kiez | 6 |
White Plains | 5 |
Saint Petersburg | 4 |
San Francisco | 4 |
Seattle | 4 |
Stockholm | 4 |
Washington | 3 |
Brooklyn | 2 |
Concord | 2 |
Dong Ket | 2 |
Frankfurt Am Main | 2 |
Lake Mary | 2 |
Toronto | 2 |
Warrington | 2 |
Attikí | 1 |
Baltimore | 1 |
Beijing | 1 |
Chicago | 1 |
Gunzenhausen | 1 |
Harlech | 1 |
Indianapolis | 1 |
Islamabad | 1 |
Kematen | 1 |
Killington | 1 |
Mainz | 1 |
Moscow | 1 |
Notre Dame | 1 |
Novosibirsk | 1 |
Paris | 1 |
Philadelphia | 1 |
Phoenix | 1 |
Scottsdale | 1 |
Seremban | 1 |
Shenzhen | 1 |
Tampa | 1 |
Tehran | 1 |
Warsaw | 1 |